Today’s M&A deals include announcements on Sitero, Veryon, EBIS, DoseMe, Firstline, Twilio, among others.
Sitero purchases studyOS
Sitero, a technology-enabled CRO, acquired the AI assets and business of studyOS to embed autonomous, natural-language-driven trial workflow automation into its operations. The move advances Sitero’s strategy of becoming a truly AI-powered provider (branded “SiteroAI”) by combining studyOS’s Ash-platform with Sitero’s Mentor eClinical suite. The technology adds intelligent automation for study design, site activation, data review and monitoring, driving estimated 20-30 percent efficiency gains. Although the purchase price was not publicly disclosed, the deal underscores Sitero’s innovation push to shorten trial timelines and reduce costs.
Veryon Acquires EBIS
Veryon acquired EBIS to broaden its aircraft maintenance and ground-support equipment (GSE) asset-management capabilities, aiming to deliver a unified, intelligent platform for both air‐ and ground-assets. The technology integration enables Part 145 repair stations, FBOs, airlines and maintenance providers to manage maintenance workflows, asset tracking, compliance and analytics within one system—driving operational visibility, asset uptime and cost reduction. Deal value was not publicly disclosed, but the acquisition reflects a strategic push to modernize legacy systems and embed AI-driven insights into MRO operations worldwide.
DoseMe Acquires Firstline
DoseMe acquired Firstline to form an end-to-end platform combining model-informed precision-dosing with infectious-disease guidance and stewardship protocols. The technology bridges evidence-based treatment guidance, real-time local resistance data and individualized dosing, thereby improving patient outcomes, reducing antibiotic overuse and supporting institutional stewardship efforts. Though the transaction amount wasn’t disclosed, the acquisition aligns with DoseMe’s strategy of expanding from dosing software into broader clinical decision support, embedding innovation at the intersection of precision medicine and infectious-disease management.
Twilio purchases authentication & authorization management software vendor Stytch
Twilio’s acquisition of Stytch is designed to integrate a modern, developer-first identity platform into Twilio’s communications and engagement stack—anticipating a future where human and AI agents both require authentication and authorization. Stytch’s SDK-based identity infrastructure, which supports agent- and human-auth scenarios, strengthens Twilio’s ambition to deliver unified, trusted digital interactions across channels and agents. While deal financials weren’t fully disclosed in public sources, the strategic import is clear: identity becomes a foundational layer for AI-driven customer and agent engagement.
Thasniya VP
